v3.25.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Revenues    
Product revenue, net $ 168 $ 582
Operating expenses    
Cost of goods sold 14 80
Research and development 4,554 11,401
Selling, general and administrative 5,699 13,264
Total operating expenses 10,267 24,745
Loss from operations (10,099) (24,163)
Other (income) expense    
Interest expense 3,993 3,607
Interest income (279) (947)
Other (income) expense, net (6,559) (32)
Net loss $ (7,254) $ (26,791)
Basic net loss per share attributable to common stockholders (in dollars per share) $ (1.5) $ (13.89)
Diluted net loss per share attributable to common stockholders (in dollars per share) $ (1.5) $ (13.89)
Weighted average shares outstanding - basic (in shares) 4,834 1,929
Weighted average shares outstanding - diluted (in shares) 4,834 1,929